PASW
PASW
NASDAQ · Distributors

Ping An Biomedical Co Ltd

$0.16
+0.00 (+0.49%)
As of Jun 30, 10:58 PM ET ·
Financial Highlights (FY 2026)
Revenue
45.37M
Net Income
-17,042,610
Gross Margin
2.8%
Profit Margin
-37.6%
Rev Growth
-33.2%
D/E Ratio
0.22
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 2.8% 2.8% 33.1% 33.1%
Operating Margin -43.0% -38.7% 5.8% 5.9%
Profit Margin -37.6% -35.7% 4.3% 5.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 45.37M 67.91M 4.16M 3.93M
Gross Profit 1.26M 1.89M 1.37M 1.30M
Operating Income -19,530,039 -26,312,926 240.2K 230.4K
Net Income -17,042,610 -22,961,600 178.4K 196.3K
Gross Margin 2.8% 2.8% 33.1% 33.1%
Operating Margin -43.0% -38.7% 5.8% 5.9%
Profit Margin -37.6% -35.7% 4.3% 5.0%
Rev Growth -33.2% -33.2% -3.1% +16.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 353.3K 353.3K 2.56M 2.29M
Total Equity 1.60M 1.60M 2.63M 2.69M
D/E Ratio 0.22 0.22 0.97 0.85
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -19,524,615 -27,767,042 369.6K 361.5K
Free Cash Flow 206.6K 190.0K